Skip to main content

Advertisement

Table 3 The dynamic changes in LV function 6 ±1 and 35 ± 6 months after revascularisation within groups of patients with and without significant improvement in LVEF

From: Prediction of long-term segmental and global functional recovery of hibernating myocardium after revascularisation based on low dose dobutamine and late gadolinium enhancement cardiovascular magnetic resonance

Responders Baseline 6 ± 1 months 35 ± 6 months Mean diff. ± SD*** Pvalue***
LV EDVI (ml/m 2 ) 84 ±34 84 ±23 85 ±24 1.6 ±30 0.94
LV ESVI (ml/m 2 ) 55 ±24 43 ±19* 41 ±18 14 ±15 <0.001
LV SV (ml) 67 ±24 83 ±20* 92 ±27 24 ±24 <0.001
LVEF (%) 36 ±8 51 ±11* 54 ±11** 17 ±8 <0.001
MV RF (%) 22 ±11 19 ±12 16 ±10 5.0 ±10 0.021
WMSI 1.8 ±0.4 1.4 ±0.4* 1.4 ±0.5 0.4 ±0.4 <0.001
Non-responders      
LV EDVI (ml/m 2 ) 116 ±29 109 ±24 124 ±31 8.1 ±28 0.445
LV ESVI (ml/m 2 ) 77 ±24 70 ±19 82 ±26 4.6 ±21 0.575
LV SV (ml) 77 ±22 77 ±18 84 ±16 7 ±19 0.359
LVEF (%) 33 ±6 36 ±8* 35 ±5 1.3 ±3.8 0.113
MV RF (%) 21 ±14 19 ±7 21 ±13 0.4 ±18 0.859
WMSI 2.1 ±0.4 1.9 ±0.3* 2.1 ±0.3 0.03 ±0.3 0.779
  1. *LV parameters that differed significantly between the baseline and 6 ±1 month evaluations; **LV parameters that differed significantly between the 6 ±1 month and 35 ±6 month evaluations; ***p values and mean differences ±standard deviation (SD) were calculated for LV parameters assessed at baseline and at the end of the study period. Definitions of the terms and abbreviations are in the text.